Showing results (831-840 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|January 20, 2020
Safety and efficacy of nazartinib (EGF816) in adults with EGFR-mutant non-small-cell lung carcinoma: a multicentre, open-label, phase 1 studyDaniel S-W Tan, Natasha B Leighl, Gregory J Riely, et al.
The Lancet. Respiratory Medicine|November 23, 2020
Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?Christopher J Yarnell, Darryl Abrams, Matthew R Baldwin, et al.
The Lancet. Respiratory Medicine|November 16, 2020
Telomere length and risk of idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease: a mendelian randomisation studyAnna Duckworth, Michael A Gibbons, Richard J Allen, et al.
The Lancet. Respiratory Medicine|October 19, 2020
Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromesDaniel E Leisman, Lukas Ronner, Rachel Pinotti, et al.
The Lancet. Respiratory Medicine|September 5, 2020
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research prioritiesPeter M George, Paolo Spagnolo, Michael Kreuter, et al.
The Lancet. Respiratory Medicine|August 31, 2020
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational studyGiacomo Grasselli, Tommaso Tonetti, Alessandro Protti, et al.
The Lancet. Respiratory Medicine|September 1, 2020
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trialDinesh Khanna, Celia J F Lin, Daniel E Furst, et al.
The Lancet. Respiratory Medicine|January 21, 2020
Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysisRishi K Gupta, Carolin T Turner, Cristina Venturini, et al.
The Lancet. Respiratory Medicine|March 7, 2018
The global burden of paediatric and neonatal sepsis: a systematic reviewCarolin Fleischmann-Struzek, David M Goldfarb, Peter Schlattmann, et al.
The Lancet. Respiratory Medicine|March 19, 2021
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trialRobert S Wallis, Sibuse Ginindza, Trevor Beattie, et al.
Pageof 104